COMP
Price
$9.64Alerts
Change
-$0.33 (-3.31%)
Updated
Nov 20 closing price
Capitalization
7.84B
100 days until earnings call
Intraday BUY SELL Signals
CTEV
Price
$18.28Alerts
Change
-$0.75 (-3.94%)
Updated
Nov 20 closing price
Capitalization
384.88M
100 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COMP vs CTEV

COMP vs CTEV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COMP vs. CTEV commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COMP is a Hold and CTEV is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COMP with price predictions
Nov 20, 2026

COMP saw its Stochastic Oscillator recovers from the overbought zone

The Stochastic Oscillator for COMP moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 63 similar instances where the indicator exited the overbought zone. In 56 of the 63 cases the stock moved lower. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COMP as a result. In 64 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

The Moving Average Convergence Divergence Histogram (MACD) for COMP turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 36 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

The 50-day moving average for COMP moved below the 200-day moving average on November 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COMP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

COMP broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

COMP moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for COMP crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.

Following a +17.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where COMP advanced for three days, in 215 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 164 of 201 cases where COMP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. COMP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 89 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.631) is normal, around the industry mean (2.150). P/E Ratio (145.857) is within average values for comparable stocks, (55.411). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.683). Dividend Yield (0.038) settles around the average of (0.107) among similar stocks. P/S Ratio (0.686) is also within normal values, averaging (5.943).

The Tickeron PE Growth Rating for this company is 95 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for CTEV with price predictions
Nov 20, 2026

Momentum Indicator for CTEV turns negative, indicating new downward trend

CTEV saw its Momentum Indicator move below the 0 level on November 19, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In 72 of the 76 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CTEV turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

CTEV moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for CTEV moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

CTEV broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CTEV's RSI Oscillator exited the oversold zone, 26 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +26.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTEV advanced for three days, in 223 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.307) is normal, around the industry mean (4.523). P/E Ratio (-1.336) is within average values for comparable stocks, (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.562) is also within normal values, averaging (6.105).

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. CTEV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTEV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

FUNDAMENTALS RATINGS
CTEV: Fundamental Ratings
CTEV
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COMPCTEV
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
N/A
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (COMP: $9.64 vs. CTEV: $18.28)
Brand notoriety: COMP and CTEV are both not notable
COMP represents the Real Estate Development, while CTEV is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: COMP: 135% vs. CTEV: 101%
Market capitalization -- COMP: $7.84B vs. CTEV: $384.88M
COMP [@Real Estate Development] is valued at $7.84B. CTEV’s [@Services to the Health Industry] market capitalization is $384.88M. The market cap for tickers in the [@Real Estate Development] industry ranges from $487 to $63.76B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $49.18B. The average market capitalization across the [@Real Estate Development] industry is $2.92B. The average market capitalization across the [@Services to the Health Industry] industry is $3.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COMP’s FA Score shows that 0 FA rating(s) are green while CTEV’s FA Score has 2 green FA rating(s).

  • COMP’s FA Score: 0 green, 5 red.
  • CTEV’s FA Score: 2 green, 3 red.
According to our system of comparison, CTEV is a better buy in the long-term than COMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COMP’s TA Score shows that 4 TA indicator(s) are bullish while CTEV’s TA Score has 3 bullish TA indicator(s).

  • COMP’s TA Score: 4 bullish, 6 bearish.
  • CTEV’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, COMP is a better buy in the short-term than CTEV.

Price Growth

COMP (@Real Estate Development) experienced а -5.58% price change this week, while CTEV (@Services to the Health Industry) price change was -31.84% for the same time period.

The average weekly price growth across all stocks in the @Real Estate Development industry was -8.66%. For the same industry, the average monthly price growth was -15.13%, and the average quarterly price growth was -19.21%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was -12.81%. For the same industry, the average monthly price growth was -13.35%, and the average quarterly price growth was +1.75%.

Reported Earning Dates

COMP is expected to report earnings on Mar 02, 2027.

CTEV is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Real Estate Development (-8.66% weekly)

Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.

@Services to the Health Industry (-12.81% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
Interact to see
Advertisement

CTEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTEV has been loosely correlated with COMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTEV jumps, then COMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTEV
1D Price
Change %
CTEV100%
-3.94%
COMP - CTEV
36%
Loosely correlated
-3.31%
CLSK - CTEV
36%
Loosely correlated
-16.27%
RIOT - CTEV
34%
Loosely correlated
-8.46%
COIN - CTEV
32%
Poorly correlated
-6.34%
TGL - CTEV
30%
Poorly correlated
-5.13%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GIND25.990.34
+1.34%
Goldman Sachs India Equity ETF (GIND)
LSCP24.250.13
+0.56%
Natixis Loomis Sayles Dynamic Core Plus ETF (LSCP)
EBI65.35N/A
N/A
The RBB Fund Trust Longview Advantage ETF
FBTC50.58-3.32
-6.16%
Fidelity Wise Origin Bitcoin Fund (FBTC)
IREG0.47-0.26
-35.77%
Leverage Shares 2X Long IREN Daily ETF (IREG)